This website uses cookies to enhance the user experience.
||
G

GLAXOSMITHKLINE AS930 606 308

Purchase and sale
Limited company
Drammensveien 288 0283 OSLO, Norge

GLAXOSMITHKLINE AS

Operating
Drive handel og agenturvirksomhet samt konsulent- og informasjonsvirksomhet for farmasøytiske og lignende produkter og alt hva hermed står i for- bindelse. Det kan ved aksjetegning eller på annen måte interessere seg i andre foretagender.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

Chairman of the board
Years since formation
31 years
since Mar 12, 1995
Type
Limited company
VAT registered
Yes
Number of employees
77

Ownership

Number of shares and share classes
950
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2025
1,263,581,765
NOK
Annual total result 2025
29,113,500
NOK
Total equity 2025
118,107,530
NOK
Last update: Jul 16, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-

Others

NameRoleShares
D
DELOITTE AS
Auditor-
A
AMESTO ACCOUNTHOUSE AS
Accountant-
K
KPMG ACCOUNTING AS
Accountant-
Last update: Sep 27, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
G
GLAXOSMITHKLINE HOLDING AS
Ordinary shares
950
100 %
Last update: Jun 2, 2025

Group structure

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
1,263,581,765
1,038,773,036
903,087,983
853,014,648
782,165,601
Annual Total Result
29,113,500
26,171,532
20,696,970
21,142,510
22,077,450
Total assets
421,464,346
316,729,431
292,017,287
272,133,090
341,505,798
Total liabilities
303,356,816
198,627,901
175,729,788
155,845,591
225,707,209
Total equity
118,107,530
118,101,530
116,287,499
116,287,499
115,798,589

P&L

Year20252024202320222021
Total operating income
1,263,581,765
1,038,773,036
903,087,983
853,014,648
782,165,601
Total operating costs
1,225,584,298
1,005,426,682
877,658,447
827,406,064
755,729,786
Operating result
37,997,467
33,346,354
25,429,536
25,608,584
26,435,815
Financial income/costs
858,514
1,537,448
2,359,810
2,339,966
2,707,950
Profit before tax
38,855,981
34,883,802
27,789,346
27,948,550
29,143,765
Total tax & extraordinary income/cost
9,742,481
8,712,270
7,092,376
6,806,040
7,066,315
Annual Total Result
29,113,500
26,171,532
20,696,970
21,142,510
22,077,450

Balance overview

Year20252024202320222021
Total fixed assets
86,133,665
84,547,878
81,674,600
76,818,270
79,744,903
Total current assets
335,330,682
232,181,553
210,342,687
195,314,820
261,760,895
Total assets
421,464,346
316,729,431
292,017,287
272,133,090
341,505,798
Short term debt
303,356,816
198,627,901
175,729,788
155,845,591
225,707,209
Long term debt
0
0
0
0
0
Total liabilities
303,356,816
198,627,901
175,729,788
155,845,591
225,707,209
Contributed capital
950,000
950,000
950,000
950,000
950,000
Retained earnings
117,157,530
117,151,530
115,337,499
115,337,499
114,848,589
Total equity
118,107,530
118,101,530
116,287,499
116,287,499
115,798,589
Total equity and liabilities
421,464,346
316,729,431
292,017,287
272,133,090
341,505,798

Classification

21st company classification
BETA
Industrial large enterprise
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods